QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 becton-dickinson-sees-high-single-digit-profit-growth-ahead-plans-share-buybacks-from-waters-deal

Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments des...

 becton-dickinson-sees-fy2026-adj-eps-1475-1505-vs-1438-est

Becton Dickinson (NYSE:BDX) is looking for FY2026 Adj EPS of $14.75-$15.05 vs $14.38 analyst estimate..

 becton-dickinson-q4-adj-eps-396-beats-392-estimate-sales-5890b-miss-5902b-estimate

Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.92 ...

 becton-dickinson-and-company-announces-full-enrollment-in-its-pivotal-agility-investigational-device-exemption-trial-in-patients-with-peripheral-arterial-disease

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the i...

 bd-receives-fda-510k-clearance-and-conformit-europenne-marking-in-eu-for-enteric-bacterial-panel-and-enteric-bacterial-panel-plus-for-bd-cor-system

BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S.

 bd-unveils-bd-incada-connected-care-platform-ai-enabled-cloud-based-platform-that-unifies-bd-device-data-into-one-intelligent-ecosystem

BD (Becton, Dickinson and Company) (NYSE:BDX), a global leader in medical technology, introduces the BD Incada™ Connected Care ...

 bd-cfo-set-to-exit-company-this-december-stock-falls

Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque int...

 rbc-capital-reiterates-sector-perform-on-becton-dickinson-maintains-211-price-target

RBC Capital analyst Shagun Singh reiterates Becton Dickinson (NYSE:BDX) with a Sector Perform and maintains $211 price target.

 becton-dickinson-sees-q4-sales-5900b-vs-5912b-est

Becton Dickinson (NYSE:BDX) sees Q4 sales of $5.900 billion vs $5.912 billion analyst estimate.

 becton-dickinson-narrows-fy2025-sales-guidance-from-21800b-21900b-to-21800b-vs-21863b-est

Becton Dickinson (NYSE:BDX) narrows FY2025 sales outlook from $21.800 billion-$21.900 billion to $21.800 billion vs $21.863 bil...

 bd-enrolls-first-patient-in-xtract-registry-to-evaluate-rotarex-catheter-for-peripheral-artery-disease-treatment

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the enrollment of t...

 bd-and-opentrons-announce-multi-year-collaboration-to-integrate-robotic-liquid-handling-capabilities-into-bd-single-cell-multiomics-instruments-automating-critical-experimental-steps

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Opentrons Labworks, Inc., recog...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

 this-biogen-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION